Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 4)
Blood Platelet Disorders (Phase 1/Phase 2)
Blood Transfusion (Phase 2)
Dupuytren Contracture (Phase 2/Phase 3)
Extracorporeal Membrane Oxygenation (Phase 4)
General Surgery (Phase 4)
Healthy Volunteers (Phase 2)
Heart Defects, Congenital (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemorrhage (Phase 4)
Infections (Phase 3)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neutropenia (Phase 2)
Platelet Aggregation Inhibitors (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 2)
Thrombocytopenia (Phase 4)
Thromboembolism (Phase 4)
Venous Thromboembolism (Phase 2)
Wounds and Injuries (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue